ClinicalTrials.gov
public full text
Public Domain
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
The purpose of this study is to evaluate the effect of AMG 747 on negative symptoms of schizophrenia in patients who are stable on current antipsychotic treatment. After a run-in period on their current antipsychotic treatment, patients will be randomized to one of the four treatment arms as add-on therapy for a treatment duration of up to 3 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia#1114936
- A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome#1008503
- Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease#1172502
- Optimizing Prescribing of Antipsychotics in Long-Term Care#826475
- MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users#1113506
Record · ID 1058344
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive